Heartland Bank & Trust Co Makes New $246,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Heartland Bank & Trust Co purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 713 shares of the company's stock, valued at approximately $246,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Atwood & Palmer Inc. bought a new stake in HCA Healthcare during the 1st quarter worth about $28,000. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $36,000. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the period. Finally, Legacy Investment Solutions LLC raised its holdings in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after purchasing an additional 95 shares during the period. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the transaction, the chief operating officer now owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on HCA shares. Guggenheim started coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price target for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Royal Bank Of Canada decreased their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Barclays set a $416.00 target price on shares of HCA Healthcare and gave the stock an "overweight" rating in a research report on Monday, June 2nd. Finally, Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $392.47.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $377.26 on Monday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm has a market capitalization of $90.76 billion, a P/E ratio of 16.77, a P/E/G ratio of 1.30 and a beta of 1.49. The company's 50 day moving average price is $362.30 and its two-hundred day moving average price is $334.94.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm earned $5.36 earnings per share. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.